Heading to ADA2019 sessions to discuss exciting advancements in diabetes care.pic.twitter.comrVCNT7BbQq

Heading to #ADA2019 sessions to discuss exciting advancements in diabetes care.pic.twitter.com/rVCNT7BbQq

14:05 EDT 8 Jun 2019 | Merck & Co., Inc.

Heading to #ADA2019 sessions to discuss exciting advancements in diabetes care. pic.twitter.com/rVCNT7BbQq

More From BioPortfolio on "Heading to #ADA2019 sessions to discuss exciting advancements in diabetes care.pic.twitter.com/rVCNT7BbQq"